Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Wintergreen oil inhalation for shortness of breath in pneumonia patients

Official title: The Effects of Wintergreen Essential Oil Inhalation on Alleviating Dyspnea Among Patients With Pneumonia

Run by Far Eastern Memorial Hospital · NCT07894835 · Data updated 2026-11-12

Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.

More Pneumonia trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment84 (estimated)
SponsorFar Eastern Memorial Hospital
Academic / other
Locations1 site (New Taipei City, Taipei)
StatusRecruiting
StartedOctober 19, 2026
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedOctober 26, 2026
Trial IDNCT07894835 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–90 with a primary pneumonia diagnosis and dyspnea, able to communicate in Mandarin or Taiwanese and without contraindicating conditions.

Probably not a fit

Patients with severe nasal disease, salicylate allergy, dementia, pregnancy, or on certain respiratory supports may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, non-blinded study will enroll 84 hospitalized pneumonia patients and assign them to seven groups to receive different inhaled preparations, including wintergreen oil at several concentrations, a placebo, a positive control, or routine care. Inhalations occur three times daily for three days, using a small amount of oil on gauze held near the nose for brief breaths. Researchers will measure breathing effort, oxygen levels, blood lactate, lung function, lab markers, and patient-reported comfort before and after the intervention.

Why it matters

Potential benefit: If successful, wintergreen inhalation could provide a simple, noninvasive option to ease dyspnea in pneumonia patients.

How similar studies have gone: Previous aromatherapy approaches have shown mixed results; this study explores a structured, dose-ranging inhalation strategy in pneumonia.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Primary diagnosis of pneumonia with dyspnea symptoms.
2. Admitted with ICD-10 diagnosis codes: Influenza and viral pneumonia (J10-J12), Bacterial pneumonia (J13-J15), Other infectious agents (J16-J17), or Unspecified organism pneumonia (J18.9).
3. Aged 18 to 90 years.
4. Clear consciousness (Glasgow Coma Scale: 15) with normal mental and behavioral capacity.
5. Able to communicate verbally or non-verbally and comprehend Mandarin or Taiwanese.

Exclusion Criteria:

1. Dementia (including Alzheimer's disease, Parkinson's disease, etc.).
2. Acute psychiatric symptoms precluding communication.
3. Known allergy or hypersensitivity to salicylates, aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs).
4. Anosmia or severe nasal diseases.
5. Pregnant or lactating women.
6. Currently receiving non-invasive positive pressure ventilation (NIPPV, BiPAP), high-flow nasal cannula (HFNC), or oxygen masks (such as Simple mask, Non-rebreathing mask).
7. History of asthma.
8. History of very severe chronic obstructive pulmonary disease (COPD): GOLD stage 4 (FEV1 \< 30% predicted).

Where it's running

  • Far Eastern Memorial Hospital
    New Taipei City, Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions

    This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.

    Recruiting University of Campinas, Brazil · Campinas, São Paulo · NCT06772922

  • Observing symptoms in children with first-onset bronchial asthma

    This study looks at how asthma shows up in kids and teens aged 3 to 18, especially if they have unusual symptoms like a chronic cough, to see if a specific questionnaire can help spot these cases better.

    Recruiting Charles University, Czech Republic · Prague · NCT06201494

  • Assessing diaphragm function in patients with respiratory diseases

    This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.

    Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT05903001

  • A large biobank for acute and emergency medicine

    This study is collecting health information and samples from patients with sudden illnesses in the Emergency Department to see if it can help improve treatments and predict how patients will do.

    Recruiting University Medical Center Groningen · Groningen · NCT04615065

  • Respiratory Physiotherapy in Critically Ill Pneumonia Patients

    This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.

    Recruiting Hospital H+ Queretaro · Querétaro · NCT07909616

  • AI-powered CT help to guide pneumonia care

    A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.

    Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895290

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.